Alliance, NCI Networks Launch Intergrated Lung Cancer Trials Called ALCHEMIST

The Alliance for Clinical Trials in Oncology, in conjunction with the National Cancer Institute (NCI) and ECOG-ACRIN Cancer Research Group, today launched the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST – three trials to identify patients with early-stage lung cancer who have tumors that contain uncommon genetic changes and evaluate whether drug treatments aimed at those changes can improve their survival. As lead network group, the Alliance


UPCOMING MEETINGS

2014 Fall Group Meeting
open to all Alliance members
November 5-8, 2014
Loews Chicago O'Hare
5300 N. River Road
Rosemont, IL 60018
Meeting schedule

2015 Summer Group Meeting
open to all Alliance members
May 14-16, 2015
Loews Chicago O'Hare
5300 N. River Road
Rosemont, IL 60018

TWEETS

FROM THE NCI

RSS Feed Widget